$25.81
-0.65 (-2.46%)
LTH News2 articles
Quince Therapeutics Engages LifeSci for Strategic Review Amid Phase 3 Setback
Quince Therapeutics shares fell 6.6% in premarket trading after hiring LifeSci Capital to explore strategic alternatives and debt restructuring, following a failed Phase 3 trial and board resignations.
China Life Insurance Shares Dip Ahead of Key Inflation Data Release
China Life Insurance's A-shares fell 0.75% to 47.47 yuan as markets closed Friday, with investors awaiting January inflation figures due February 11. The broader Shanghai Composite declined 0.25%.